Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-19 · accession 0000899243-21-033848 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2021-08-20 | 2021-08-19 | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $99.49 | -20.0K | 208.8K | -9% | -$1.99M |
| D | 2021-08-20 | 2021-08-19 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $1.03 | +12.0K | 1.03M | +1% | +$12.4K |
| D | 2021-08-20 | 2021-08-19 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.00 | -12.0K | 359.3K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-19 | S | D | 400 | $96.38 | 222,600 | I By John M. Evans, III 2018 Irrevocable Trust | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $96.07 to $96.97, inclusive. |
| 2 | Common | Common Stock | 2021-08-19 | S | D | 1,000 | $97.50 | 221,600 | I By John M. Evans, III 2018 Irrevocable Trust | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $97.22 to $97.85, inclusive. |
| 3 | Common | Common Stock | 2021-08-19 | S | D | 3,140 | $98.74 | 218,460 | I By John M. Evans, III 2018 Irrevocable Trust | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $98.33 to $98.99, inclusive. |
| 4 | Common | Common Stock | 2021-08-19 | M | A | 12,000 | $1.03 | 1,033,525 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-19 | S | D | 300 | $101.00 | 203,000 | I By John M. Evans, III 2018 Irrevocable Trust | — | — | |
| 6 | Common | Common Stock | 2021-08-19 | S | D | 5,456 | $100.35 | 203,300 | I By John M. Evans, III 2018 Irrevocable Trust | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $100.04 to $100.99, inclusive. |
| 7 | Common | Common Stock | 2021-08-19 | S | D | 9,704 | $99.53 | 208,756 | I By John M. Evans, III 2018 Irrevocable Trust | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $99.01 to $99.95, inclusive. |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-08-19 | M | D | 12,000 | $0.00 | 359,345 | D | $1.03 · — to 2028-07-13 | 12,000 Common Stock | (F7) The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested. |